home All News open_in_new Full Article

Las vacunas contra la Covid de Pfizer y Moderna siguen siendo superventas a pesar de caer sus ventas tras la pandemia

En 2024, los ingresos por estos productos superaron los 1.000 millones de dólares. Más información: El cruce de demandas por las patentes de la vacuna contra la Covid-19 ya implica a 10 compañías farmacéuticas


today 3 w. ago attach_file Science

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 258327580
Add Watch Country

arrow_drop_down